Skip navigation
Skip navigation

Health technology assessment and haemophilia

Farrugia, Albert; O'Mahony, B; Cassar, J


Although the funding of rare diseases such as haemophilia in developing countries remains a low priority, pressures on the funding of haemophilia treatment are also emerging in developed economies affected by the global economic downturn and the other demands on health care budgets. This is leading advisory bodies and payers alike to explore the tools of Health Technology Assessment (HTAs) in deriving recommendations for reimbursement policies. In particular, the use of cost utility analysis...[Show more]

CollectionsANU Research Publications
Date published: 2012
Type: Journal article
Source: Haemophilia
DOI: 10.1111/j.1365-2516.2012.02754.x


File Description SizeFormat Image
01_Farrugia_Health_technology_assessment_2012.pdf74.33 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator